REVEFENACIN vs REVUMENIB: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
REVEFENACIN vs REVUMENIB: Safety Overview
| Metric | REVEFENACIN | REVUMENIB |
|---|---|---|
| Total FAERS Reports | 280 | 371 |
| Deaths Reported | 11 | 49 |
| Death Rate | 3.9% | 13.2% |
| Hospitalizations | 23 | 93 |
| Average Patient Age | 72.4 yrs | 46.4 yrs |
| % Female Patients | 59.1% | 47.6% |
| FDA Approval Date | Nov 9, 2018 | Nov 15, 2024 |
| Manufacturer | Viatris Specialty LLC | Syndax Pharmaceuticals, Inc. |
| Route | RESPIRATORY (INHALATION) | ORAL |
| Marketing Status | Prescription | Prescription |